Facilities

Manufacturing

Kudo Biotechnology has built a state-of-the-art cGMP mRNA Pilot Manufacturing facility in Minhang, Shanghai. Spanning over 5,300m², our facility accommodates two plasmid lines, three mRNA lines, two LNP bulk lines, and one drug product fill & finish line. These production lines fulfill manufacturing needs for preclinical through Phase 2 clinical trials, and our facility architecture has capacity to manufacture up to 40 million vials/ year.